![Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-022-01668-0/MediaObjects/41375_2022_1668_Fig1_HTML.png)
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia
![Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology](https://www.frontiersin.org/files/Articles/469178/fonc-09-00863-HTML-r1/image_m/fonc-09-00863-g001.jpg)
Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
![Frontiers | Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Frontiers | Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia](https://www.frontiersin.org/files/Articles/81229/fonc-04-00054-HTML/image_m/fonc-04-00054-g002.jpg)
Frontiers | Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
![Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia: Molecular Therapy - Nucleic Acids Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/76e1ca46-30ec-49c1-b325-a7c53fedc91f/fx1_lrg.jpg)
Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia: Molecular Therapy - Nucleic Acids
![Schematic representation of BCR and ABL1 gene structures and essential... | Download Scientific Diagram Schematic representation of BCR and ABL1 gene structures and essential... | Download Scientific Diagram](https://www.researchgate.net/publication/328580053/figure/fig1/AS:962678705098752@1606531897003/Schematic-representation-of-BCR-and-ABL1-gene-structures-and-essential-protein-domains-of.png)
Schematic representation of BCR and ABL1 gene structures and essential... | Download Scientific Diagram
![BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance | Journal of Hematology & Oncology | Full Text BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1756-8722-4-6/MediaObjects/13045_2010_Article_140_Fig3_HTML.jpg)